Captrust Financial Advisors Penumbra Inc Transaction History

Captrust Financial Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$116.09 - $227.33 $232 - $454	-2 Reduced 0.9%	219 $27,000
Q2 2022 Aug 16, 2022	BUY	$116.09 - $227.33 $8,010 - $15,685	69 Added 45.39%	221 $28,000
Q1 2022 May 16, 2022	BUY	$187.51 - $283.98 $1,500 - $2,271	8 Added 5.56%	152 $34,000
Q4 2021 Feb 14, 2022	BUY	$238.08 - $288.0 $11,904 - $14,400	50 Added 53.19%	144 $41,000
Q3 2021 Nov 16, 2021	SELL	$250.72 - $291.24 $22,815 - $26,502	-91 Reduced 49.19%	94 $25,000
Q2 2021 Aug 16, 2021	BUY	$235.0 - $310.7 $24,205 - $32,002	103 Added 125.61%	185 $51,000
Q1 2021 May 17, 2021	BUY	$175.6 - $291.43 $2,985 - $4,954	17 Added 26.15%	82 $22,000
Q4 2020 Feb 16, 2021	BUY	$174.98 - $272.83 $874 - $1,364	5 Added 8.33%	65 $11,000
Q3 2020 Nov 17, 2020	BUY	$185.27 - $238.73 $11,116 - $14,323	60 New	60 $11,000

370

29.1M

220K

158K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.